Additionally, the underlying molecular pathway of the axonal dysfunction was PAD-mediated activation of a protein phosphatase 1-glycogen synthase kinase-3β (PP1-GSK3β) signaling cascade [40, 42, 58, 59]. This evidence concerns the gene GSK3B and peripheral arterial disease.